Date: Wednesday, September 23, 2020Time: 11am ET / 8am PTDuration: 1 Hour
Whether you’re developing a COVID-19 treatment or introducing a new drug to the pharmaceutical market, serialization is a necessary investment. Why not implement a solution that will get you to compliance faster, future-proof your deployments and reduce total cost of ownership?
The benefits of implementing configurable rather than customized software for rapid and consistent serialization deployment to achieve compliance now and address changing market requirements in the future.
Why productized, configurable and expandable packaging technology offers key advantages when considering long-term maintenance, upgrade and support—for overall lower cost of ownership.
Real-world examples of how leading pharma companies were able to serialize new lines—fully validated and in full production—within six months.
Want to reach 216,000+ Fierce Life Sciences Weekly subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy.
